Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 31–45 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5903 CYP17A1 Genetic Sequencing (NGS) for 17α‑Hydroxylase Deficiency Test This test evaluates the CYP17A1 gene for pathogenic variants associated with 17α‑hydroxylase deficiency, a form of congenital adrenal hyperplasia.	Whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CYP17A1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting required", "Do not discontinue prescribed medications unless advised by your physician"] Indications ["Suspected 17α‑hydroxylase deficiency based on clinical presentation and biochemical findings", "Family history of congenital adrenal hyperplasia", "Carrier screening in families with known CYP17A1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E25.0 Clinical summary This test evaluates the CYP17A1 gene for pathogenic variants associated with 17α‑hydroxylase deficiency, a form of congenital adrenal hyperplasia.
TEST-4627 DARS Gene Hypomyelination with Brainstem and Spinal Cord Involvement and Leg Spasticity (Genetic Test) This genetic test identifies mutations and copy number variations within the DARS gene, which are associated with hypomyelination with brainstem and spinal cord involvement and leg...	Peripheral whole blood (3–5 ml in EDTA), extracted DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DARS gene sequence", "Copy Number Variations (CNV) in DARS gene"] Parameters [] Preparation ["No special fasting required", "Genetic counseling recommended prior to testing"] Indications ["Suspected diagnosis of hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL)", "Family history of HBSL", "Need for recurrence risk assessment", "Carrier testing for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94101-2 ICD-10: G37.8 Clinical summary This genetic test identifies mutations and copy number variations within the DARS gene, which are associated with hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL).
TEST-6322 DDOST Gene CDG Type Ir (Genetic Test) This genetic test evaluates the DDOST gene for mutations associated with Congenital Disorder of Glycosylation Type Ir (CDG-Ir).	Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in DDOST gene", "Small indels in DDOST gene", "Copy number variations in DDOST gene"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Clinical suspicion of CDG-Ir", "Family history of CDG-Ir", "Confirmation of diagnosis after biochemical screening"] Measurement technique Confirm with laboratory Codes LOINC: 92880-1 ICD-10: E77.8 Clinical summary This genetic test evaluates the DDOST gene for mutations associated with Congenital Disorder of Glycosylation Type Ir (CDG-Ir).
TEST-5054 DLG3 Gene Mental Retardation, X‑Linked Type 90 Genetic Test This genetic test evaluates the DLG3 gene for pathogenic variants associated with X-linked intellectual disability type 90.	Whole blood, DNA FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DLG3 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Clinical history and genetic counselling session with pedigree chart required before testing."] Indications ["Suspected X-linked intellectual disability", "Family history of XLID90", "Clinical features consistent with DLG3-related intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81261-4 ICD-10: F78.1 Clinical summary This genetic test evaluates the DLG3 gene for pathogenic variants associated with X-linked intellectual disability type 90.
TEST-3464 DUOXA2 Gene Thyroid Dyshormonogenesis Type 5 Genetic Test This test evaluates the DUOXA2 gene for pathogenic variants associated with thyroid dyshormonogenesis type 5.	Peripheral Blood (Venipuncture or Finger-prick on FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DUOXA2 gene sequence", "Pathogenic variants in DUOXA2"] Parameters [] Preparation [] Indications ["Newborns with abnormal TSH screening", "Family history of thyroid dyshormonogenesis", "Congenital hypothyroidism"] Measurement technique Confirm with laboratory Codes LOINC: 90037-0 ICD-10: E03.0 Clinical summary This test evaluates the DUOXA2 gene for pathogenic variants associated with thyroid dyshormonogenesis type 5.
TEST-2916 EFNB1 Gene Craniofrontonasal Syndrome Genetic Test This test evaluates the EFNB1 gene for pathogenic variants associated with Craniofrontonasal Syndrome.	Peripheral Whole Blood (EDTA) or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EFNB1 gene"] Parameters [] Preparation ["No fasting or special preparation needed"] Indications ["Suspected Craniofrontonasal Syndrome", "Family history of CFNS", "Genetic counselling for CFNS"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.0 Clinical summary This test evaluates the EFNB1 gene for pathogenic variants associated with Craniofrontonasal Syndrome.
TEST-2624 EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test This test identifies pathogenic variants in the EFTUD2 gene, which are associated with Mandibulofacial Dysostosis with Microcephaly (MFDM).	Peripheral whole blood (3–5 mL in K2EDTA tube), extracted genomic DNA, or FTA card blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EFTUD2 gene coding region", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [{"name": "Precision / Coverage", "reference_range": "Full coding region + splice sites; detects SNVs, indels, and copy number variants (CNVs)"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with ≥100× mean read depth"}] Preparation ["No fasting or special preparation required"] Indications ["Microcephaly", "Malar hypoplasia", "Micrognathia", "External ear anomalies", "Conductive hearing loss", "Developmental delay", "Characteristic craniofacial dysmorphism"] Measurement technique Confirm with laboratory Codes LOINC: 92734-7 ICD-10: Q75.4 Clinical summary This test identifies pathogenic variants in the EFTUD2 gene, which are associated with Mandibulofacial Dysostosis with Microcephaly (MFDM).
TEST-3480 EIF2AK3 Gene Sequencing Test for Wolcott‑Rallison Syndrome This test identifies pathogenic variants in the EIF2AK3 gene, confirming a molecular diagnosis of Wolcott‑Rallison syndrome.	Peripheral whole blood (EDTA) or DNA FTA card	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EIF2AK3 gene sequence", "Pathogenic variants (missense, nonsense, indels, splice-site)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Suspected Wolcott‑Rallison syndrome", "Neonatal diabetes with dysmorphic features", "Family history of Wolcott‑Rallison syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: E11.8 Clinical summary This test identifies pathogenic variants in the EIF2AK3 gene, confirming a molecular diagnosis of Wolcott‑Rallison syndrome.
TEST-2660 FGF10 Gene LADD Syndrome Genetic Test This test analyzes the FGF10 gene for pathogenic variants associated with Lacrimo-Auriculo-Dento-Digital (LADD) Syndrome.	Peripheral Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGF10 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Formal clinical referral from a licensed physician required"] Indications ["Clinical suspicion of LADD syndrome", "Characteristic dysmorphic features", "Unexplained congenital anomalies affecting face, ears, teeth, or digits"] Measurement technique Confirm with laboratory Codes LOINC: 82255-5 ICD-10: Q87.8 Clinical summary This test analyzes the FGF10 gene for pathogenic variants associated with Lacrimo-Auriculo-Dento-Digital (LADD) Syndrome.
TEST-2688 FGFR1 Gene (Kallmann Syndrome Type 2) Genetic Test This genetic test evaluates the FGFR1 gene for pathogenic variants associated with Kallmann syndrome type 2.	Whole Blood or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FGFR1 gene", "Copy Number Variants (CNVs) in FGFR1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Diagnosis of Kallmann syndrome type 2", "Family risk assessment for Kallmann syndrome", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 77999-5 ICD-10: E23.0, R43.0 Clinical summary This genetic test evaluates the FGFR1 gene for pathogenic variants associated with Kallmann syndrome type 2.
TEST-2457 FGFR1 Gene Osteoglophonic Dysplasia Genetic Test This genetic test analyzes the FGFR1 gene for pathogenic variants associated with osteoglophonic dysplasia.	Whole Blood (EDTA), Extracted DNA, or FTA Card (Peripheral Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR1 gene sequence", "Pathogenic variants in FGFR1"] Parameters [] Preparation [] Indications ["Suspected osteoglophonic dysplasia", "Family history of osteoglophonic dysplasia", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 92681-3 ICD-10: Q78.8 Clinical summary This genetic test analyzes the FGFR1 gene for pathogenic variants associated with osteoglophonic dysplasia.
TEST-4729 FKBP10 Gene Osteogenesis Imperfecta Type XI Genetic Test This test evaluates the FKBP10 gene for pathogenic variants associated with Osteogenesis Imperfecta Type XI.	Peripheral whole blood (3–5 mL in EDTA) or FTA card dried blood spots	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FKBP10 gene", "Copy Number Variations (CNV) in the FKBP10 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Individuals with clinical features suggestive of Osteogenesis Imperfecta Type XI", "Family history of Osteogenesis Imperfecta Type XI", "Reproductive risk assessment", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 83019-6 ICD-10: Q78.0; Z15.89; Z84.8 Clinical summary This test evaluates the FKBP10 gene for pathogenic variants associated with Osteogenesis Imperfecta Type XI.
TEST-6396 FTCD Gene Glutamate Formiminotransferase Deficiency Genetic Test This genetic test analyzes the FTCD gene to identify mutations associated with glutamate formiminotransferase deficiency.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FTCD gene sequence", "Pathogenic variants in coding exons and splice sites"] Parameters [] Preparation ["Genetic counselling session required", "Provide three-generation pedigree", "Bring current medications and previous test results"] Indications ["Biochemical suspicion of FTCD deficiency", "Confirmation of clinical diagnosis", "Carrier detection", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E72.8 Clinical summary This genetic test analyzes the FTCD gene to identify mutations associated with glutamate formiminotransferase deficiency.
TEST-4926 FTSJ1 Gene X-Linked Intellectual Disability Type 44 Genetic Test This test detects pathogenic variants in the FTSJ1 gene, which are associated with X-linked intellectual disability type 44 (XLID44). It utilizes Next Generation Sequencing (NGS) f...	Whole Blood, Extracted DNA, or DNA FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in FTSJ1 gene", "Single nucleotide variants (SNVs)", "Small insertions or deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Submit comprehensive clinical history including developmental milestones, cognitive assessments, and family pedigree.", "Mandatory pre-test genetic counselling session required."] Indications ["Diagnosis of suspected XLID44", "Carrier screening for at-risk family members", "Prenatal diagnosis", "Preimplantation genetic testing (PGT)"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: F78.A1 Clinical summary This test detects pathogenic variants in the FTSJ1 gene, which are associated with X-linked intellectual disability type 44 (XLID44). It utilizes Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-6378 G6PC Gene Sequencing for Glycogen Storage Disease Type Ia (GSD-Ia) Test This diagnostic test evaluates the G6PC gene for pathogenic variants associated with Glycogen Storage Disease Type Ia (von Gierke disease). It identifies mutations causing enzyme d...	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the G6PC gene", "Glucose-6-phosphatase enzyme activity (indirectly via genetic analysis)"] Parameters [] Preparation ["No specific fasting required for blood sample", "Inform lab of any medications"] Indications ["Suspected Glycogen Storage Disease Type Ia (GSD-Ia)", "Family history of GSD-Ia", "Need for definitive molecular diagnosis", "Carrier screening in families with GSD-Ia"] Measurement technique Confirm with laboratory Codes LOINC: 21656-4 ICD-10: E74.01 Clinical summary This diagnostic test evaluates the G6PC gene for pathogenic variants associated with Glycogen Storage Disease Type Ia (von Gierke disease). It identifies mutations causing enzyme deficiency leading to metabolic dysfunction.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.